Ryanodine receptor stabilization therapy suppresses Ca(2+)- based arrhythmias in a novel model of metabolic HFpEF. Kaplan AD, Boyman L, Ward CW, Lederer WJ, et al. J Mol Cell Cardiol 2024;195:68-72.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kaplan AD, Boyman L, Ward CW, Lederer WJ, et al. Ryanodine receptor stabilization therapy suppresses Ca(2+)- based arrhythmias in a novel model of metabolic HFpEF. J Mol Cell Cardiol 2024;195:68-72.
PMID: 39053573